<DOC>
	<DOCNO>NCT02889614</DOCNO>
	<brief_summary>Familial hypobetalipoproteinemia ( FHBL , OMIM # 1707730 ) genetic disorder heterozygotic LDL-C metabolism . Clinical manifestation range asymptomatic patient metabolic ( fatty liver , diabetes ) psychiatric disorder still unrecognized . HYPOPSY research , aim evaluate prevalence hypobetalipoproteinemia , characterize specific relate psychiatric disorder .</brief_summary>
	<brief_title>Prevalence Assessment Characterization Psychological Disorders Associated With Hypobetalipoproteinemia</brief_title>
	<detailed_description>Familial hypobetalipoproteinemia ( FHBL , OMIM # 1707730 ) genetic disorder heterozygotic LDL-C metabolism ( Low Density Lipoprotein - Cholesterol ) whose incidence measure 1 : 500 1 : 1000 . These heterozygous individual may asymptomatic present clinical ( fatty liver , diabetes ) psychiatric manifestation still unrecognized . Moreover , individual mostly longevity syndrome cardiovascular protection . The FHBL often due mutation APOB ( APOlipoprotein B ) , major component LDL , VLDL ( Very Low Density Lipoprotein ) chylomicron , case , loss-of-function mutation serine protease PCSK9 , endogenous inhibitor LDL receptor . HYPOPSY research , aim evaluate , population psychiatric disorder , prevalence hypobetalipoproteinemia , characterize specific relate psychiatric disorder .</detailed_description>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Hypobetalipoproteinemias</mesh_term>
	<criteria>Patients admit mental Disorders Unit Nantes University Hospital Minor patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>